Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1[Glentek 50 mg compresse rivestite con film]----1件: 18 💬
2[J05AG04]----1件: 18 💬
3[PTC743]----2件: 18, 21 💬
4[VO659]1件: VO659---2件: 8, 18 💬
5AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV) gene transfer vector expressing the cDNA coding for human FXN----1件: 18 💬
6Alpha-tocotrienol quinone2件: Tocotrienol,
Vatiquinone		1件: Vatiquinone 💬 --3件: 18, 21, 156 💬
7Alpha-tocotrienolquinone----1件: 18 💬
8Antrodia cinnamomea Products----1件: 18 💬
9ARO-ATXN2 Injection----1件: 18 💬
10Artesunate1件: Artesunate1件: Artesunate 💬 --4件: 18, 66, 86, 96 💬
11Artesunate Oral Product1件: Artesunate1件: Artesunate 💬 --1件: 18 💬
12Baclofen1件: Baclofen1件: Baclofen 💬 2件: GABBR1,
GABBR2 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬8件: 2, 10, 13, 18, 65, 70, 149, 206 💬
13Behavioral: Aerobic Training----1件: 18 💬
14Behavioral: Balance Training----3件: 6, 13, 18 💬
15Behavioral: Balance training by means of conventional rehabilitation----1件: 18 💬
16Behavioral: Balance training over stabilometric platform----1件: 18 💬
17Behavioral: High-Intensity Aerobic Exercise Prior to Balance Training----1件: 18 💬
18Behavioral: Low-Intensity Exercise Prior to Balance Training----1件: 18 💬
19Behavioral: Tai chi----1件: 18 💬
20BHV-4157----1件: 18 💬
21BIIB132----1件: 18 💬
22BINOCRIT*1SIR 40000UI/1ML----1件: 18 💬
23Bupropion1件: Bupropion3件: Bupropion hydrochloride ,
Bupropion ,
Bupropion hydrobromide 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬7件: 8, 18, 21, 96, 97, 171, 298 💬
24Bupropion & Citalopram2件: Bupropion,
Citalopram		5件: Bupropion hydrochloride ,
Citalopram hydrobromide ,
Bupropion ,
Citalopram ,
Bupropion hydrobromide 💬 		3件: SLC6A2,
SLC6A3,
SLC6A4 💬 		9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 18 💬
25C-Trelin OD Tab(5mg Taltirelin Hydrate)1件: Taltirelin---1件: 18 💬
26Cabaletta for IV infusion once weekly during 24 weeks----1件: 18 💬
27CAD-1883----1件: 18 💬
28Calcitriol1件: Calcitriol1件: Calcitriol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬11件: 18, 37, 46, 49, 66, 96, 158, 223, 235, 238, 326 💬
29Chinese medicine WT----1件: 18 💬
30Citalopram1件: Citalopram2件: Citalopram hydrobromide ,
Citalopram 💬 		1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬7件: 6, 8, 13, 18, 46, 98, 127 💬
31Coenzyme Q10----11件: 2, 5, 6, 8, 10, 18, 49, 57, 107, 113, 193 💬
32Conventional medicine----1件: 18 💬
33CTI-1601----1件: 18 💬
34DEFERIPRONE1件: Deferiprone1件: Deferiprone 💬 --7件: 2, 6, 18, 121, 122, 139, 233 💬
35DHA----1件: 18 💬
36Diagnostic Test: Blood analysis for hypercalcemia's control----1件: 18 💬
37Diagnostic Test: Blood Draw - Baseline----1件: 18 💬
38Diagnostic Test: Blood Draw - Follow-up 12 months----1件: 18 💬
39Diagnostic Test: Blood Draw - Follow-up 24 months----1件: 18 💬
40Diagnostic Test: Buccal Swabs and Blood Draws----1件: 18 💬
41Diagnostic Test: Buccal Swabs, Blood Draws and Skin Punch Biopsy----1件: 18 💬
42Diagnostic Test: Clinical Scales - Baseline----1件: 18 💬
43Diagnostic Test: Clinical Scales - Follow-up 12 months----1件: 18 💬
44Diagnostic Test: Clinical Scales - Follow-up 24 months----1件: 18 💬
45Diagnostic Test: Molecular Diagnosis----1件: 18 💬
46Diagnostic Test: Quality of Life Assessment - Baseline----1件: 18 💬
47Diagnostic Test: Quality of Life Assessment - Follow-up 12 months----1件: 18 💬
48Diagnostic Test: Quality of Life Assessment - Follow-up 24 months----1件: 18 💬
49DT-216----1件: 18 💬
50DT-216P2----1件: 18 💬
51EGB 761 (r) 120 mg----1件: 18 💬
52EGb 761 120 mg----1件: 18 💬
53Elamipretide1件: Elamipretide2件: Elamipretide ,
Elamipretide hydrochloride 💬 		--3件: 18, 21, 324 💬
54Epoeitin beta----1件: 18 💬
55Epoetin alfa----3件: 13, 18, 46 💬
56EPREX*1FL 40000UI/ML 1ML----1件: 18 💬
57EPREX*1SIR 10000UI 1ML----1件: 18 💬
58EPREX*1SIR 40000UI/ML 1ML----2件: 2, 18 💬
59ERYTHROPOIETIN1件: Erythropoietin4件: Epoetin alfa ,
Epoetin epsilon ,
Epoetin theta ,
Epoetin zeta 💬 		1件: EPOR 💬 7件: Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬11件: 2, 6, 13, 18, 22, 47, 61, 63, 70, 95, 96 💬
60ETRAVIRINA----1件: 18 💬
61Etravirine1件: Etravirine1件: Etravirine 💬 --1件: 18 💬
62Etravirine Tablets1件: Etravirine1件: Etravirine 💬 --1件: 18 💬
63EU1/97/031-032----1件: 18 💬
64EU1/97/031/031-032----1件: 18 💬
65Excipients----1件: 18 💬
66Fampridine 10 mg prolonged-release tablet (per os)----1件: 18 💬
67Flumazenil1件: Flumazenil1件: Flumazenil 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬5件: 6, 13, 17, 18, 206 💬
68Fursultiamine1件: Fursultiamine2件: Fursultiamine ,
Fursultiamine hydrochloride 💬 		--2件: 6, 18 💬
69GABAPENTIN1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		10件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬7件: 6, 13, 18, 19, 70, 226, 298 💬
70Gabapentine 300mg1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		10件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬2件: 13, 18 💬
71Gamma interferon----1件: 18 💬
72GBP----2件: 13, 18 💬
73Genetic: All Participants----1件: 18 💬
74Genetic: ASP2016----1件: 18 💬
75Genetic: High Dose LX20061件: LX2006---1件: 18 💬
76Genetic: Low dose LX20061件: LX2006---1件: 18 💬
77Genetic: Mid Dose LX20061件: LX2006---1件: 18 💬
78Ginkgo biloba1件: Ginkgo biloba1件: Ginkgo 💬 --4件: 13, 18, 47, 90 💬
79Glentek 50 mg compresse rivestite con film----1件: 18 💬
80Glentek 50 mg film-coated tablets----1件: 18 💬
81Granocyte----1件: 18 💬
82H-116PI-DE.pdf----1件: 18 💬
83High-dose intravenous immunoglobulin (IVIG)----1件: 18 💬
84Idebenone1件: Idebenone1件: Idebenone 💬 --9件: 6, 8, 13, 17, 18, 21, 113, 115, 302 💬
85Imukin----3件: 18, 58, 228 💬
86IMUKIN - 6 FLACONI 0.5 ML 100 MCG----2件: 18, 58 💬
87IMUKIN*SC 6F 0,5ML 100MCG----1件: 18 💬
88INTELENCE----1件: 18 💬
89INTELENCE - 200 MG - COMPRESSA -USO ORALE - FLACONE (HDPE) 60 COMPRESSE----1件: 18 💬
90Interferon Gamma1件: Interferon Gamma---9件: 18, 65, 85, 96, 107, 228, 299, 301, 326 💬
91INTERFERON GAMMA-1B2件: Interferon Gamma,
Interferon gamma-1b		1件: Interferon gamma-1b 💬 2件: IFNGR1,
IFNGR2 💬 		18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬7件: 18, 65, 85, 228, 299, 301, 326 💬
92Intranasal infusion----1件: 18 💬
93Intrathecal infusion----1件: 18 💬
94Intrathecal injection----2件: 2, 18 💬
95Intravenous Infusion----3件: 6, 18, 51 💬
96Iron1件: Iron1件: Ferrous fumarate 💬 --7件: 18, 60, 96, 97, 238, 254, 284 💬
97Iron chelating intervention1件: Iron1件: Ferrous fumarate 💬 --1件: 18 💬
98IVIG----8件: 11, 13, 14, 18, 51, 63, 65, 172 💬
99KPS-0373----1件: 18 💬
100KPS-0373, High dose----1件: 18 💬
101KPS-0373, Low dose----1件: 18 💬
102Lenograstim1件: Lenograstim1件: Lenograstim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬8件: 2, 13, 16, 18, 19, 57, 65, 97 💬
103Leucine1件: Leucine1件: Leucine 💬 --13件: 5, 6, 7, 18, 19, 65, 96, 97, 127, 280, 283, 284, 299 💬
104LITHIUM CARBONATE1件: Lithium carbonate1件: Lithium carbonate 💬 --6件: 2, 13, 17, 18, 127, 310 💬
105LITIO CARBONATO----3件: 2, 17, 18 💬
106Lu AA24493----1件: 18 💬
107LX20061件: LX2006---1件: 18 💬
108Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬51件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
109MIB-626----1件: 18 💬
110MIN-102----2件: 18, 20 💬
111N-Acetyl-L-Leucine1件: Leucine1件: Leucine 💬 --3件: 18, 19, 65 💬
112Neo-Recormon----1件: 18 💬
113NeoRecormon1件: Epoetin beta1件: Epoetin beta 💬 1件: EPOR 💬 7件: Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬2件: 13, 18 💬
114Nerve Growth Factor1件: Nerve Growth Factor---5件: 2, 3, 18, 53, 90 💬
115Neurontin 300 mg hard capsule----2件: 13, 18 💬
116Nicotinamide1件: Nicotinamide1件: Niacinamide 💬 --19件: 2, 5, 6, 7, 8, 17, 18, 21, 46, 49, 60, 63, 65, 85, 97, 107, 162, 191, 302 💬
117Nicotinamide riboside2件: Nicotinamide,
Nicotinamide riboside		1件: Niacinamide 💬 --14件: 2, 5, 6, 7, 8, 17, 18, 21, 49, 60, 65, 85, 97, 191 💬
118NL-ATN1-001----1件: 18 💬
119NL-ATN1-002----1件: 18 💬
120Nomlabofusp1件: Nomlabofusp---1件: 18 💬
121Omaveloxolone1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
122Omaveloxolone Capsules, 10 mg1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
123Omaveloxolone Capsules, 150 mg1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
124Omaveloxolone Capsules, 160 mg1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
125Omaveloxolone Capsules, 2.5 mg1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
126Omaveloxolone Capsules, 20 mg1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
127Omaveloxolone Capsules, 300 mg1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
128Omaveloxolone Capsules, 40 mg1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
129Omaveloxolone Capsules, 5 mg1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
130Omaveloxolone Capsules, 80 mg1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
131Other: Blood analysis for frataxin's level measurement----1件: 18 💬
132Other: Blood draw----17件: 2, 6, 11, 13, 18, 39, 46, 57, 77, 84, 85, 86, 88, 96, 97, 167, 299 💬
133Other: Exercise intervention----3件: 13, 18, 60 💬
134Other: Spinal tap for CSF collection----1件: 18 💬
135Other: Venipuncture for blood sample----1件: 18 💬
136PREDNISOLONE1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬48件: 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
137Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬58件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
138PS659----2件: 8, 18 💬
139PTC743----2件: 18, 21 💬
140Resveratrol1件: Resveratrol---10件: 2, 6, 8, 18, 46, 57, 89, 97, 113, 299 💬
141RHuG-CSF----1件: 18 💬
142Right Heart Catheterization----1件: 18 💬
143RILUZOLE1件: Riluzole1件: Riluzole 💬 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬9件: 2, 3, 5, 8, 13, 17, 18, 203, 206 💬
144Riluzole PMCS1件: Riluzole1件: Riluzole 💬 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 18 💬
145RILUZOLO----3件: 2, 18, 114 💬
146Rokan (r) Novo 120 mg----1件: 18 💬
147Rosuvastatin1件: Rosuvastatin2件: Rosuvastatin calcium ,
Rosuvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬16件: 6, 18, 46, 49, 51, 56, 57, 62, 65, 67, 79, 94, 96, 97, 271, 299 💬
148Saline----12件: 2, 6, 13, 17, 18, 53, 67, 77, 86, 97, 168, 299 💬
149SKYCLARYS (omaveloxolone)1件: Omaveloxolone1件: Omaveloxolone 💬 1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
150SLS-005----2件: 2, 18 💬
151Sodium phenylbutyrate1件: Phenylbutyric acid1件: Sodium phenylbutyrate 💬 --5件: 2, 3, 8, 18, 251 💬
152Standardized Ginkgo Biloba Extract (EGb 761 (r)1件: Ginkgo biloba1件: Ginkgo 💬 --1件: 18 💬
153Stemchymal----1件: 18 💬
154Stemchymal®----1件: 18 💬
155SUB09246MIG----1件: 18 💬
156TAK-831----1件: 18 💬
157Taltirelin1件: Taltirelin---1件: 18 💬
158Tocotrienol1件: Tocotrienol---4件: 18, 21, 156, 299 💬
159Trehalose1件: Trehalose---4件: 2, 6, 18, 113 💬
160Troriluzole1件: Troriluzole2件: Troriluzole ,
Troriluzole hydrochloride 💬 		14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 18 💬
161Umbilical cord mesenchymal stem cell----2件: 18, 113 💬
162VARENICLINE1件: Varenicline2件: Varenicline tartrate ,
Varenicline 💬 		2件: CHRNA4,
CHRNB2 💬 		5件: Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬4件: 6, 18, 53, 298 💬
163VATIQUINONE1件: Vatiquinone1件: Vatiquinone 💬 --2件: 18, 21 💬
164VO6591件: VO659---2件: 8, 18 💬